{"id":1787,"date":"2026-10-06T13:18:59","date_gmt":"2026-10-06T13:18:59","guid":{"rendered":"https:\/\/dev.ich.org\/index.php\/public-consultations\/q1\/"},"modified":"2026-10-06T13:18:59","modified_gmt":"2026-10-06T13:18:59","slug":"q1","status":"publish","type":"consultation","link":"https:\/\/dev.ich.org\/index.php\/public-consultations\/q1\/","title":{"rendered":"Q1 Public Consultation"},"content":{"rendered":"<p>The ICH Q1 draft Guideline on Stability Testing of Drug Substances and Drug Products reached Step 2b of the ICH process on 11 April 2025 and was released for public consultation. Each ICH Regulatory Member runs its own regional consultation with the deadline listed below.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Public consultation on the ICH Q1 draft Guideline on Stability Testing of Drug Substances and Drug Products, released at Step 2b on 11 April 2025.<\/p>\n","protected":false},"featured_media":0,"template":"","guideline_category":[18],"guideline_tag":[],"class_list":["post-1787","consultation","type-consultation","status-publish","hentry","guideline_category-quality"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/consultation\/1787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/consultation"}],"about":[{"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/types\/consultation"}],"version-history":[{"count":0,"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/consultation\/1787\/revisions"}],"wp:attachment":[{"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/media?parent=1787"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/guideline_category?post=1787"},{"taxonomy":"guideline_tag","embeddable":true,"href":"https:\/\/dev.ich.org\/index.php\/wp-json\/wp\/v2\/guideline_tag?post=1787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}